Antibiotic-loaded bone cement is a specialized formulation of PMMA bone cement that incorporates antibiotics to prevent and treat prosthetic joint infections, a serious complication of joint replacement and other orthopedic surgeries. Antibiotic-loaded bone cements are increasingly used in joint replacement surgeries, driven by the need to reduce the risk of prosthetic joint infections, which can lead to revision surgery, increased morbidity, and significant healthcare costs [citation:MRFR]. Antibiotic-loaded bone cements are used in both primary and revision joint replacement surgeries, and the most commonly used antibiotics are gentamicin, tobramycin, and vancomycin .

Antibiotic-loaded bone cement (ALBC) can be used both prophylactically, to prevent infection in high-risk patients, and therapeutically, to treat an established infection. The antibiotics are released from the cement over time, providing a high local concentration of the drug at the surgical site, which is more effective than systemic antibiotics alone. The development of high-viscosity formulations with enhanced antibiotic elution profiles is further improving the efficacy of ALBC. The use of antibiotic-loaded bone cement is becoming a standard of care in many orthopedic practices, driven by the growing awareness of the devastating consequences of prosthetic joint infections and the evidence supporting the efficacy of ALBC in reducing infection rates. The market for antibiotic-loaded bone cement is expected to grow, driven by the increasing number of joint replacement surgeries and the growing focus on patient safety and infection prevention. By 2035, antibiotic-loaded bone cement is expected to be a key component of infection prevention strategies in orthopedic surgery.

Future Outlook: Orthopedic Bone Cement Casting Material Market Forecast 2035

Get More Insights: Orthopedic Bone Cement Casting Material Market Report